Current best evidence on prescribed drugs

Drugdocs Logo

Current best evidence on prescribed drugs

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Nextstellis

Chemical Namedrospirenone and estetrol
Dosage FormTablet (oral; 24 pink active tablets each containing drospirenone 3 mg and estetrol 14.2 mg, and 4 white inert tablets)
Drug ClassHormones
SystemFemale reproductive
CompanyMayne Pharma
Approval Year2021

Indication

  • Indicated for use by females of reproductive potential to prevent pregnancy
Last updated on 3/14/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Nextstellis (drospirenone and estetrol) Prescribing Information.2021Mayne Pharma, Greenville, NC
Document TitleYearSource
A multicenter, open-label, single-arm study to evaluate the contraceptive efficacy and safety of a combined oral contraceptive containing 15 mg estetrol and 3 mg drospirenone.2020Estetra